Protective effects of YC-1 against glutamate induced PC12 cell apoptosis

Cellular and Molecular Neurobiology

Volumn 31, Issue 2, 2011, Pages 303-311

  Yang, Xiaofan ^a   Wang, Yucheng ^a   Luo, Jia ^a   Liu, Shichang ^a   Yang, Zhuo ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

Apoptosis; Glutamate; ODQ; PC12cell; YC 1

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CYCLIC GMP; GLUTAMIC ACID; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; LIFICIGUAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; EXCITABILITY; FLOW CYTOMETRY; NEUROPROTECTION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; STAINING;

ANIMALS; APOPTOSIS; BISBENZIMIDAZOLE; CELL SHAPE; CELL SURVIVAL; CYCLIC GMP; DRUG SYNERGISM; GLUTAMATES; INDAZOLES; OXADIAZOLES; PC12 CELLS; PROTECTIVE AGENTS; QUINOXALINES; RATS; STAINING AND LABELING;

EID: 79959739958     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-010-9622-9     Document Type: Article

References (50)

1. Ankarcrona M, Dypbukt JM, Orrenius S, Nicotera P (1996) Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett 394:321-324 (Pubitemid 26341466)
2. Bleich S, Romer K, Wiltfang J, Kornhuber J (2003) Glutamate and the glutamate receptor system: a target for drug action. Int J Geriatr Psychiatry 18:S33-S40 (Pubitemid 37150476)
3. Bredt DS (2003) Nitric oxide signaling in brain: potentiating the gain with YC-1. Mol Pharmacol 63:1206-1208
4. Cary SPL, Winger JA, Marletta MA (2005) Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP. P Natl Acad Sci USA 102:13064-13069 (Pubitemid 41324979)
5. Cary SPL, Winger JA, Derbyshire ER, Marletta MA (2006) Nitric oxide signaling: no longer simply on or off. Trends Biochem Sci 31:231-239
6. Chien WL, Liang KC, Teng CM, Kuo SC, Lee FY, Fu WM (2005) Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1. Eur J Neurosci 21:1679-1688
7. Chien WL, Liang KC, Fu WM (2008) Enhancement of active shuttle avoidance response by the NO-cGMP-PKG activator YC-1. Eur J Pharmacol 590:233-240
8. Choi DW, Rothman SM (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13:171-182 (Pubitemid 20100647)
9. Chun YS, Yeo EJ, Choi E, Teng CM, Bae JM, Kim MS, Park JW (2001) Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. Biochem Pharmacol 61:947-954 (Pubitemid 32247383)
10. Conn PJ (2003) Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann N Y Acad Sci 1003:12-21
11. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695 (Pubitemid 23350687)
12. Dawson VL, Kizushi VM, Huang PL, Snyder SH, Dawson TM (1996) Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci 16:2479-2487 (Pubitemid 26122672)
13. Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277 (Pubitemid 16080782)
14. Derbyshire ER, Marletta MA (2009) Biochemistry of soluble guanylate cyclase. Handb Exp Pharmacol:17-31
15. Estevez AG, Spear N, Thompson JA, Cornwell TL, Radi R, Barbeito L, Beckman JS (1998) Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotrophic factor. J Neurosci 18:3708-3714 (Pubitemid 28225678)
16. Farinelli SE, Park DS, Greene LA (1996) Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J Neurosci 16:2325-2334 (Pubitemid 26154343)
17. Fiscus RR (1988) Molecular mechanisms of endothelium-mediated vasodilation. Semin Thromb Hemost 14 Suppl:12-22
18. Fiscus RR, Robles BT, Waldman SA, Murad F (1987) Atrial natriuretic factors stimulate accumulation and efflux of cyclic GMP in C6-2B rat glioma and PC12 rat pheochromocytoma cell cultures. J Neurochem 48:522-528 (Pubitemid 17005163)
19. Fiscus RR, Tu AW, Chew SB (2001) Natriuretic peptides inhibit apoptosis and prolong the survival of serum-deprived PC12 cells. Neuroreport 12:185-189 (Pubitemid 32114348)
20. Flamigni F, Facchini A, Stanic I, Tantini B, Bonavita F, Stefanelli C (2001) Control of survival of proliferating L1210 cells by soluble guanylate cyclase and p44/42 mitogen-activated protein kinase modulators. Biochem Pharmacol 62:319-328 (Pubitemid 32575332)
21. Floyd RA, Hensley K (2002) Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23:795-807
22. Friebe A, Schultz G, Koesling D (1996) Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J 15:6863-6868 (Pubitemid 27023257)
23. Froissard P, Duval D (1994) Cytotoxic effects of glutamic acid on PC12 cells. Neurochem Int 24:485-493 (Pubitemid 24169907)
24. Funasaka T, Yanagawa T, Hogan V, Raz A (2005) Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia. FASEB J 19:1422-1430 (Pubitemid 41279000)
25. Garthwaite G, Garthwaite J (1988) Cyclic GMP and cell death in rat cerebellar slices. Neuroscience 26:321-326
26. Garthwaite G, Goodwin DA, Neale S, Riddall D, Garthwaite J (2002) Soluble guanylyl cyclase activator YC-1 protects white matter axons from nitric oxide toxicity and metabolic stress, probably through Na(+) channel inhibition. Mol Pharmacol 61:97-104 (Pubitemid 34049516)
27. Gerstner B, Lee J, DeSilva TM, Jensen FE, Volpe JJ, Rosenberg PA (2009) 17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J Neurosci Res 87:2078-2086
28. Greene LA (1978) Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J Cell Biol 78:747-755
29. Hoenicka M, Becker EM, Apeler H, Sirichoke T, Schroder H, Gerzer R, Stasch JP (1999) Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide. J Mol Med 77:14-23 (Pubitemid 29146177)
30. Hsieh GC, O'Neill AB, Moreland RB, Sullivan JP, Brioni JD (2003) YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats. Eur J Pharmacol 458:183-189 (Pubitemid 36050718)
31. Ibrahim M, Derbyshire ER, Soldatova AV, Marletta MA, Spiro TG (2010) Soluble Guanylate Cyclase Is Activated Differently by Excess NO and by YC-1: Resonance Raman Spectroscopic Evidence. Biochemistry-Us 49:4864-4871
32. Ishima T, Nishimura T, Iyo M, Hashimoto K (2008) Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors. Prog Neuropsychopharmacol Biol Psychiatry 32:1656-1659
33. Kim YM, Chung HT, Kim SS, Han JA, Yoo YM, Kim KM, Lee GH, Yun HY, Green A, Li J, Simmons RL, Billiar TR (1999) Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J Neurosci 19:6740-6747 (Pubitemid 29380102)
34. Kuribayashi K, Kitaoka Y, Kumai T, Munemasa Y, Isenoumi K, Motoki M, Kogo J, Hayashi Y, Kobayashi S, Ueno S (2006) Neuroprotective effect of atrial natriuretic peptide against NMDA-induced neurotoxicity in the rat retina. Brain Res 1071:34-41 (Pubitemid 43255473)
35. Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330:613-622
36. Miller LN, Nakane M, Hsieh GC, Chang R, Kolasa T, Moreland RB, Brioni JD (2003) A-350619: a novel activator of soluble guanylyl cyclase. Life Sci 72:1015-1025 (Pubitemid 36001981)
37. Mulsch A, Bauersachs J, Schafer A, Stasch JP, Kast R, Busse R (1997) Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol 120:681-689 (Pubitemid 27089418)
38. Ndountse LT, Chan HM (2009) Role of N-methyl-D-aspartate receptors in polychlorinated biphenyl mediated neurotoxicity. Toxicol Lett 184:50-55
39. Pan SL, Guh JH, Chang YL, Kuo SC, Lee FY, Teng CM (2004) YC-1 prevents sodium nitroprusside-mediated apoptosis in vascular smooth muscle cells. Cardiovasc Res 61:152-158 (Pubitemid 38056691)
40. Pan SL, Guh JH, Peng CY, Wang SW, Chang YL, Cheng FC, Chang JH, Kuo SC, Lee FY, Teng CM (2005) YC-1[3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models. J Pharmacol Exp Ther 314:35-42
41. Parathath SR, Gravanis I, Tsirka SE (2007) Nitric oxide synthase isoforms undertake unique roles during excitotoxicity. Stroke 38:1938-1945 (Pubitemid 46847272)
42. Rukenstein A, Rydel RE, Greene LA (1991) Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J Neurosci 11:2552-2563
43. Stasch JP, Hobbs AJ (2009) NO-independent, haem-dependent soluble guanylate cyclase stimulators. Handb Exp Pharmacol 191:277-308
44. Stasch JP, Becker EM, Alonso-Alija C, Apeler H, Dembowsky K, Feurer A, Gerzer R, Minuth T, Perzborn E, Pleiss U, Schroder H, Schroeder W, Stahl E, Steinke W, Straub A, Schramm M (2001) NO-independent regulatory site on soluble guanylate cyclase. Nature 410:212-215 (Pubitemid 32216593)
45. Thippeswamy T, Morris R (1997) Cyclic guanosine 3′,5′- monophosphate-mediated neuroprotection by nitric oxide in dissociated cultures of rat dorsal root ganglion neurones. Brain Res 774:116-122 (Pubitemid 28007890)
46. Urushitani M, Nakamizo T, Inoue R, Sawada H, Kihara T, Honda K, Akaike A, Shimohama S (2001) N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx. J Neurosci Res 63:377-387
47. Vanhoutte PM (1997) Endothelial dysfunction and atherosclerosis. Eur Heart J 18 (Suppl E):E19-29
48. Wu CC, Ko FN, Kuo SC, Lee FY, Teng CM (1995) YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol 116:1973-1978
49. Wu CH, Chang WC, Chang GY, Kuo SC, Teng CM (2004) The inhibitory mechanism of YC-1, a benzyl indazole, on smooth muscle cell proliferation: an in vitro and in vivo study. J Pharmacol Sci 94:252-260
50. Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC, Kim MS, Park JW (2003) YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 95:516-525 (Pubitemid 36511622)